Search Results 411-420 of 16395 for infliximab
Radioactive substances linked to monoclonal antibodies can bind to cancer cells and give off radiation which may help kill cancer cells. It is not yet known ...
Osimertinib is used to treat non-small cell lung cancer (NSCLC) in patients who have certain types of abnormal epidermal growth factor (EGFR) genes. This ...
This phase Ib/II clinical trial studies the side effects and best dose of venetoclax and how well it works when given together with vincristine liposomal in ...
Treatment (within 4 months of Day 1) with biological immunomodulators, such as TNF-α inhibitors (eg, infliximab, adalimumab) or antifibrotics (pirfenidone ...
This Phase III, multicenter, double-blind, placebo-controlled treat-through study will evaluate the efficacy and safety of induction and maintenance therapy ...
A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis Patients Who Are Naive to TNF Inhibitors.
This medicine is available only with your doctor's prescription. This product is available in the following dosage forms: Capsule. Back to top ...
Explore a comprehensive list of prescription and over-the-counter medications starting with the letter “S” to learn about drug side effects, proper use and ...
The purpose of this study is to evaluate the effectiveness of MK-7240 compared to Placebo as assessed by the proportion of participants achieving clinical ...
Pirfenidone and nintedanib are approved for treatment of idiopathic pulmonary fibrosis (IPF), but questions remain regarding indications and timing of ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!